Suffered harm from Celebrex? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.

The U.S. FDA (Food and Drug Administration) required the manufacturer to add a new warning to the Celebrex label, and it was changed to reflect the increased risk of cardiovascular (CV) events. The new warning is a “black-box” warning – the highest level of caution the FDA expresses before pulling a drug off the market, and it means that the warning will display prominently on all Celebrex containers in a black box. The FDA has requested increased warnings on all NSAIDs, including Advil and Aleve, which state the risks of CV events and also major gastrointestinal (GI) problems such as stomach bleeding.

Still, all COX-2 inhibitors, including Celebrex – a class of NSAIDs that is prescription-only – are being more heavily studied because they appear to have a higher risk of CV events than just ibuprofen. Vioxx and Bextra, another Pfizer drug, have already been removed from the market because of their unacceptably high risks for CV events and skin reactions. Celebrex is currently one step away from that. Detailed research and clinical trials are underway to further understand its side effects and those of other COX-2 inhibitors, but results of some trials aren’t expected until 2010. In 2008, Celebrex was one of the drugs doctors surveyed said they would not take themselves.

Lawsuits, including Celebrex class action lawsuits, will become more common as more people are seriously injured or experience ill health due to its dangerous side effects.

Suffered harm from Celebrex? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.